Tag: Prescription Drugs
Biosimilar Biologics Do Not Always Reduce Out-of-Pocket Costs
Findings seen in large study of commercially insured outpatients examining seven biologics, before and after biosimilar availability
Use of Medications for Alcohol Use Disorder Improves Outcomes
Reduction seen in incidence of composite outcome of all-cause mortality, return to hospital with MAUD initiation at discharge
Relugolix Beneficial for Prostate Cancer Patients Undergoing Radiotherapy
Short- or longer-term relugolix achieves sustained castration in patients with localized and advanced prostate cancer
ACC: Small but Significant Risk for Cardiomyopathy Seen With ADHD Meds
Risk for cardiomyopathy increased with duration of treatment for adults aged 20 to 40 years with ADHD
ADHD Medications Linked to Reduction in Psychiatric Hospitalizations
Reduced risk for psychiatric, nonpsychiatric hospitalization seen with use of ADHD meds among adolescents, adults with ADHD
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
Among patients with atopic dermatitis and self-reported race other than White, 68.3 percent achieved EASI 75 at week 16
AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe Alopecia
Patients achieving SALT score ≤20 increased from 44.5 to 75.8 percent at week 52 to week 76
ADHD Meds Initiation Linked to Lower Rate of All-Cause Mortality
Significantly lower rates seen for all-cause mortality and unnatural-cause mortality, but not natural-cause mortality
AAN: Monoclonal Antibodies for MS During Breastfeeding Not Harmful
No association seen for mAb during breastfeeding with infant hospitalization, systemic antibiotic use, developmental delay
Long-Acting Injectable ART Superior to Standard Care for Poorly Adherent People With HIV
Key secondary end points of virologic failure and treatment-related failure met predefined stopping criterion
